According to the database analysis form Kaplan-Meier plotter, PDCD6 (HR = 0.55, 95% CI: 0.4–0.75, and P = 0.00013), GNG5 (HR = 0.73, 95% CI: 0.54–0.89, and P = 0.034), PHF6 (HR = 0.68, 95% CI: 0.51–0.92, and P = 0.011) and MAL2 (HR = 0.68, 95% CI: 0.5–0.91, and P = 0.01) seem to be the favorable factor for BLCA patients’ prognosis. The gene discussed is MAL2; the disease is bladder transitional cell carcinoma.